2013 | Capecitabine and cisplatin with or without cetuximab for patients with previously untreated advanced gastric cancer (EXPAND): a randomised, open-label phase 3 trial | LANCET ONCOLOGY |
2008 | Capecitabine and doxorubicin combination chemotherapy as salvage therapy in pretreated advanced gastric cancer. | CANCER CHEMOTHERAPY AND PHARMACOLOGY |
2017 | Cardiotoxicity of trastuzumab in patients with HER2-positive gastric cancer
| ONCOTARGET |
2018 | Casein Kinase 2 Inhibitor, CX-4945, as a Potential Targeted Anticancer Agent in Gastric Cancer | ANTICANCER RESEARCH |
2011 | CD44-SLC1A2 gene fusions in gastric cancer.
| SCIENCE TRANSLATIONAL MEDICINE |
2003 | cDNA Microarray Experiment: Design Issues in Early Stage and the Need of Normalization
| CANCER RESEARCH AND TREATMENT |
2007 | Cetuximab rescue a patient with non-small cell lung cancer from rapid disease progression during chemotherapy | ACTA ONCOLOGICA |
2020 | Changes in taste and food preferences in breast cancer patients receiving chemotherapy: a pilot study | SUPPORTIVE CARE IN CANCER |
2017 | Changes in telomerase activity due to alternative splicing of human telomerase reverse transcriptase in colorectal cancer
| ONCOLOGY LETTERS |
2002 | Changes of telomerase activity and proliferation by inhibition of reverse transcriptase activity in human cancer cell.
| CANCER RESEARCH AND TREATMENT |
2009 | Changes of telomerase activity by alternative splicing of full-length and beta variants of hTERT in breast cancer patients. | ONCOLOGY RESEARCH |
1999 | Changes of telomerase and telomere lengths in paired normal and cancer tissues of breast | International Journal of Oncology |
2007 | Changing patterns of prognosticators during 15-year follow-up of advanced gastric cancer after radical gastrectomy and adjuvant chemotherapy: A 15-year follow-up study at a single korean institute | ANNALS OF SURGICAL ONCOLOGY |
2013 | Changing treatment patterns in elderly patients with resectable colon cancer | ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY |
1994 | Changing trends in histologic types of lung cancer during the last decade(1981-1990) in Korean Hospital-based study | LUNG CANCER |
2010 | Chemokine growth-regulated oncogene 1 as a putative biomarker for gastric cancer progression | CANCER SCIENCE |
2008 | Chemoradiotherapy with or without consolidation chemotherapy using cisplatin and 5-fluorouracil in anal squamous cell carcinoma: long-term results in 31 patients
| BMC CANCER |
2020 | Chimeric Antigen Receptor T Cell Therapy Targeting ICAM-1 in Gastric Cancer
| MOLECULAR THERAPY-ONCOLYTICS |
2010 | Circulating endothelial progenitor cells (EPC) for tumor vasculogenesis in gastric cancer patients | CANCER LETTERS |
2016 | Circulating Plasma Biomarkers for TSU-68, an Oral Antiangiogenic Agent, in Patients with Metastatic Breast Cancer.
| CANCER RESEARCH AND TREATMENT |
2013 | Circulating vascular endothelial growth factor receptor 2/pAkt-positive cells as a functional pharmacodynamic marker in metastatic colorectal cancers treated with antiangiogenic agent | INVESTIGATIONAL NEW DRUGS |
2011 | Clinical significance of progesterone receptor and HER2 status in estrogen receptor-positive, operable breast cancer with adjuvant tamoxifen. | JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY |
2010 | Clinicopathologic features of metachronous or synchronous gastric cancer patients with three or more primary sites
| CANCER RESEARCH AND TREATMENT |
2015 | Clinicopathological features and prognostic significance of HER2 expression in gastric cancer | ONCOLOGY |
2013 | Combination of CYP inhibitor with MEK/ERK inhibitor enhances the inhibitory effect on ERK in BRAF mutant colon cancer cells. | ANTICANCER RESEARCH |
2014 | Combination of docetaxel and TSU-68, an oral antiangiogenic agent, in patients with metastatic breast cancer previously treated with anthracycline: Randomized phase II multicenter trial | INVESTIGATIONAL NEW DRUGS |
1999 | Combined pre-operative chemotherapy with intra-arterial cisplatin and continuous intravenous adriamycin for high grade osteosarcoma | ONCOLOGY REPORTS |
2021 | Comparative efficacy and tolerability of third-line treatments for advanced gastric cancer: A systematic review with Bayesian network meta-analysis | EUROPEAN JOURNAL OF CANCER |
1997 | Comparison of biological phenotypes according to midkine expression in gastric cancer cells and their autocrine activities could be modulated by pentosan polysulfate | CANCER LETTERS |
2017 | Complementary utility of targeted next-generation sequencing and immunohistochemistry panels as a screening platform to select targeted therapy for advanced gastric cancer
| ONCOTARGET |
2016 | Comprehensive expression profiles of gastric cancer molecular subtypes by immunohistochemistry: implications for individualized therapy
| ONCOTARGET |
2019 | Comprehensive immune profiling and immune-monitoring using body fluid of patients with metastatic gastric cancer
| Journal for Immunotherapy of Cancer |
2004 | Coordination modes vs. antitumor activity: synthesis and antitumor activity of novel platinum(II) complexes of N-substituted amino dicarboxylic acids | JOURNAL OF INORGANIC BIOCHEMISTRY |
2009 | Copy number changes can be a predictor for hemoglobin reduction after S-1 monotherapy in gastric cancer | INTERNATIONAL JOURNAL OF ONCOLOGY |
1997 | Correlation between K-ras gene mutation and prognosis of patients with nonsmall cell lung carcinoma | CANCER |
2000 | Correlation of tissue and blood plasminogen activation system in breast cancer | Journal of Neurology, Neurosurgery and Psychiatry |
2009 | Cost-effectiveness analysis of adjuvant therapy for node positive breast cancer in Korea: docetaxel, doxorubicin and cyclophosphamide (TAC) versus fluorouracil, doxorubicin and cyclophosphamide (FAC). | BREAST CANCER RESEARCH AND TREATMENT |
2016 | Cumulative Metformin Use and Its Impact on Survival in Gastric Cancer Patients After Gastrectomy | ANNALS OF SURGERY |
2005 | Cyclic induction of senescence with intermittent AZT treatment accelerates both apoptosis and telomere loss | BREAST CANCER RESEARCH AND TREATMENT |
2008 | Cyclooxygenase-2 expression in pretreatment biopsy as a predictor of tumor responses after preoperative chemoradiation in rectal cancer | ARCHIVES OF SURGERY |
2017 | Depth of response is a significant predictor for long-term outcome in advanced gastric cancer patients treated with trastuzumab
| ONCOTARGET |
2021 | Detection of asymptomatic recurrence improves survival of gastric cancer patients
| CANCER MEDICINE |
2005 | Determination of genes related to gastrointestinal tract origin cancer cells using a cDNA microarray
| CLINICAL CANCER RESEARCH |
2021 | Development and validation of a serum microRNA biomarker panel for detecting gastric cancer in a high-risk population
| GUT |
2019 | Differences in the Efficacies of Pazopanib and Gemcitabine/Docetaxel as Second-Line Treatments for Metastatic Soft Tissue Sarcoma | Oncology |
2007 | Different criteria for HER2 positivity by IHC can be applied in post-chemotherapy specimens in determining HER2 as a prognosticator in locally advanced breast cancer | BREAST CANCER RESEARCH AND TREATMENT |
1998 | Different expression patterns of MMP-2 and MMP-9 in breast cancer | ONCOLOGY REPORTS |
2005 | Different role of functional domains of hTR in DNA binding to telomere and telomerase reconstruction
| FEBS LETTERS |
2017 | Differential Prognostic Implications of Gastric Signet Ring Cell Carcinoma: Stage Adjusted Analysis From a Single High-volume Center in Asia
| ANNALS OF SURGERY |
2024 | Discovery of novel 1H-benzo[d]imidazole-4,7-dione based transglutaminase 2 inhibitors as p53 stabilizing anticancer agents in renal cell carcinoma | BIOORGANIC CHEMISTRY |
2008 | Disease Prediction Using Ranks of Gene Expressions
| Genomics & Informatics |
2011 | DNA methylation predicts recurrence from resected stage III proximal colon cancer
| CANCER |
2015 | Do Recent Advances in Diagnostic and Therapeutic Procedures Negate the Benefit of Postmastectomy Radiotherapy in N1 Patients With a Low Risk of Locoregional Recurrence?
| MEDICINE |
2009 | Docetaxel versus paclitaxel combined with 5-FU and leucovorin in advanced gastric cancer: combined analysis of two phase II trials.
| CANCER RESEARCH AND TREATMENT |
2015 | Dovitinib (TKI258), a multi-target angiokinase inhibitor, is effective regardless of KRAS or BRAF mutation status in colorectal cancer
| AMERICAN JOURNAL OF CANCER RESEARCH |
2016 | Droplet digital polymerase chain reaction detection of HER2 amplification in formalin fixed paraffin embedded breast and gastric carcinoma samples. | EXPERIMENTAL AND MOLECULAR PATHOLOGY |
2001 | Early Postoperative Intraperitoneal Chemotherapy with Mitomycin C, 5-Fluorouracil and Cisplatin for Advanced Gastric Cancer | ONCOLOGY |
2009 | Effect of being overweight on postoperative morbidity and long-term surgical outcomes in proximal gastric carcinoma | JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY |
2019 | Effect of First-line S-1 Plus Oxaliplatin With or Without Ramucirumab Followed by Paclitaxel Plus Ramucirumab on Advanced Gastric Cancer in East Asia: The Phase 2 RAINSTORM Randomized Clinical Trial | JAMA Network Open |
2017 | Effects of hormone receptor status on the durable response of trastuzumab-based therapy in metastatic breast cancer | BREAST CANCER RESEARCH AND TREATMENT |